Cargando…
Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
BACKGROUND: Elderly people who reside in long-term care facilities form a frail and vulnerable population, with multiple pathologies and high percentages of cognitive and functional disability. OBJECTIVES: The aims of this study were to assess the safety of vaccination against severe acute respirato...
Autores principales: | Montejano-Hervás, Pablo, Gómez-Pavón, Javier, Tornero-Torres, Olga, Valverde-Moyar, Mª Victoria, Martín Cruz, Beatriz, Vela Carbonera, Maribel, Fuentes-Irigoyen, Raquel, Tejada González, Pilar, González-Becerra, Margarita, Higueras Sánchez, Esther, Ramos Cordero, Primitivo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261238/ https://www.ncbi.nlm.nih.gov/pubmed/35794430 http://dx.doi.org/10.1007/s40266-022-00959-6 |
Ejemplares similares
-
Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
por: Bauernfeind, Stilla, et al.
Publicado: (2021) -
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru
por: Vargas-Herrera, Natalia, et al.
Publicado: (2022) -
Immunogenicity of a BNT162b2 vaccine booster in health-care workers
por: Saiag, Esther, et al.
Publicado: (2021) -
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
por: Frenck, Robert W., et al.
Publicado: (2021) -
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
por: Zurac, Sabina, et al.
Publicado: (2022)